← Back to Search

Intrauterine Device

Immediate insertion for Pregnancy

Phase 4

Waitlist Available

Led By Wendy V. Norman, Ph.D

Research Sponsored by University of British Columbia

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 60 months

Awards & highlights

Study Summary

This trial is testing whether or not placing an IUC (intrauterine contraception) immediately after a second trimester abortion will result in fewer pregnancies than the current standard practice of intended placement at 4 weeks post-abortion.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 60 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~60 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Pregnancy rate at one year

Secondary outcome measures

Rates at one year for Expulsion, Continuation of use, Satisfaction with method, Adverse events.

Trial Design

2Treatment groups

Experimental Treatment

Group I: 2Experimental Treatment1 Intervention

Interval insertion (two to four weeks post abortion) of either a LNG-IUC or a Copper T380 IUD after 12-24 abortion

Group II: 1Experimental Treatment1 Intervention

Immediate insertion of either a LNG-IUC or a Copper T380 IUD after 12-24 week abortion

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Immediate insertion

2011

N/A

~70

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

College of Family Physicians of CanadaOTHER

7 Previous Clinical Trials

9,344 Total Patients Enrolled

University of British ColumbiaLead Sponsor

1,418 Previous Clinical Trials

2,466,644 Total Patients Enrolled

Women's Health Research Institute of British ColumbiaOTHER

5 Previous Clinical Trials

15,845 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How reliable is the Immediate insertion procedure for patient health?

"According to our team's evaluation, Immediate insertion is considered safe enough for mass public use and was thus given a score of 3. This grade is derived from its status as a Phase 4 trial, meaning it has already been approved in the medical industry."

Answered by AI

Is this experiment actively enrolling participants?

"According to information hosted on clinicaltrials.gov, this study is not currently enrolling patients. Initially posted June 1st 2009 and last updated May 19th 2022, the trial has concluded its recruitment phase; however, 79 other trials are presently looking for participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Better Contraceptive Choices: Immediate or Delayed Insertion of IUC After Second Trimester Abortion

Wendy Norman 2009. "Better Contraceptive Choices: Immediate or Delayed Insertion of IUC After Second Trimester Abortion". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00877344.